Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVM

Alternate Symbol(s):  PAVMZ

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

Benzinga's Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact Sciences

Benzinga.com  April 27, 2018

PAVmed Signs Letter of Intent with Case Western Reserve University to Commercialize Groundbreaking EsoCheck Technology

Business Wire April 24, 2018

PAVmed Reports Fourth Quarter and Full Year 2017 Financial Results

Business Wire April 11, 2018

PAVmed Announces Final Results of Offer to Exchange Series W Warrants for Series Z Warrants

Business Wire April 5, 2018

PAVmed Announces Preliminary Results of Offer to Exchange Series W Warrants for Series Z Warrants

Business Wire April 4, 2018

PAVmed Inc. to Hold Business Update Conference Call on April 11, 2018

Business Wire April 4, 2018

Pavmed to Present at The Microcap Conference

Accesswire April 2, 2018

PAVmed Announces Extension of Offer to Exchange Series W Warrants for Series Z Warrants

Business Wire March 16, 2018

PAVmed to Present at the 28th Annual Oppenheimer Healthcare Conference

Business Wire March 14, 2018

PAVmed Initiates Offer to Exchange Outstanding Warrants

Business Wire February 21, 2018

PAVmed to Offer Opportunity to Exchange Outstanding Warrants

Business Wire February 12, 2018

PAVmed Announces Completion of Offer to Exercise Series W Warrants at a Temporarily Reduced Price

Business Wire February 9, 2018

PAVmed Announces Closing of Over-Allotment Option with Respect to Firm Commitment Common Stock Offering

Business Wire January 25, 2018

Dawson James Securities Announces the Closing of Firm Commitment Underwritten Public Offering for PAVmed Inc.

Accesswire January 23, 2018

PAVmed Announces Closing of Firm Commitment Common Stock Offering

Business Wire January 23, 2018

Mid-Morning Market Update: Markets Edge Higher; Schlumberger Earnings Top Views

Benzinga.com  January 19, 2018

PAVmed Announces Pricing of Firm Commitment Common Stock Offering

Business Wire January 19, 2018

PAVmed Announces Firm Commitment Public Offering of Common Stock

Business Wire January 18, 2018

PAVmed Sets Terms of Previously Announced Rights Offering

Business Wire January 17, 2018

PAVmed Initiates Reduction in Exercise Price of Series W Warrants

Business Wire January 11, 2018